Europe PMC
open access
Current advances in the development of Nipah virus vaccines
Nipah virus (NiV) is a highly pathogenic zoonotic agent, posing a persistent and severe threat to global public health with a mortality rate as high as 40% to 80%. With its high risk of cross-species transmission, strong cell tropism, and immune evasion capabilities, NiV has been listed as a priorit
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Immunogenicity of a Nipah Virus Vaccine#217097
- Étude des mécanismes immunitaires impliqués dans le contrôle de l'infection par le virus Nipah#796276
- Advances and Challenges in Vaccine Development for West Nile Virus (WNV) Infection#478652
- Human antibodies against West Nile and related orthoflaviviruses#154901
- Immunity Against AAV in Crigler Najjar Patient#811704
Record · ID 1166024
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive